Phio Pharmaceuticals Corp (PHIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2013 | 06-2013 | 03-2013 | 12-2012 | 09-2012 | |
| Sales | 92 | 225 | 53 | 40 | 57 |
| Gross Profit | 92 | 225 | 53 | 40 | 57 |
| Operating Expenses | 2,163 | 2,190 | 14,447 | 1,751 | 1,753 |
| Operating Income | -2,071 | -1,965 | -14,394 | -1,711 | -1,696 |
| Other Income | 12 | 4 | -3 | 0 | 52 |
| Pre-tax Income | -2,059 | -1,961 | -14,397 | -1,711 | -1,644 |
| Net Income Continuous | -2,059 | -1,961 | -14,397 | -1,711 | -1,644 |
| Net Income | $-2,059 | $-1,961 | $-14,397 | $-1,711 | $-1,644 |
| EPS Basic Total Ops | -0.30 | -0.39 | -2.76 | -0.89 | -0.56 |
| EPS Basic Continuous Ops | -0.18 | -0.18 | -2.22 | -0.74 | -0.31 |
| EPS Diluted Total Ops | -0.30 | -0.39 | -2.76 | -0.89 | -0.56 |
| EPS Diluted Continuous Ops | -0.18 | -0.18 | -2.22 | -0.74 | -0.31 |
| EBITDA(a) | $-2,046 | $-1,938 | $-14,368 | $-1,682 | $-1,657 |